Quipt Home Medical CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
The acquisition of Quipt Home Medical Corp. by 1567208 B.C. LTD and REM Aggregator, LLC has been completed, with all common shares acquired for $3.65 each.
Quipt Home Medical Corp. will be acquired by REM Aggregator, LLC and 1567208 B.C. Ltd. for $3.65 per share in cash via a plan of arrangement.
SCHEDULE 13D: Lakeview Fund Discloses 7.9% Stake in Quipt Medical
Lakeview Opportunity Fund and its affiliates have disclosed a 7.9% beneficial ownership stake in Quipt Home Medical Corp., citing an attractive investment opportunity.
Forager Capital Management has submitted an updated, immediately actionable proposal to acquire all outstanding shares of Quipt Home Medical Corp. for $3.10 per share in cash.
SCHEDULE 13D/A: Forager Capital Challenges Quipt Home Medical's Statements, Demands Retraction and Agreement Termination
Forager Capital Management has publicly denied Quipt Home Medical Corp.'s characterization of its May 17, 2025 offer as 'unsolicited' and is demanding a retraction of what it calls 'false and misleading statements' and the termination of a Non-Disclosure and Standstill Agreement.
Kanen Wealth Management LLC and its affiliated funds have filed an amended Schedule 13D, disclosing that their collective beneficial ownership in Quipt Home Medical Corp. has fallen below the 5% threshold as of May 20, 2025.
SCHEDULE 13D/A: Forager Capital Management Offers 120% Premium to Acquire Quipt Home Medical Corp. in $3.10 Cash Bid
Forager Capital Management has submitted a non-binding offer to acquire all outstanding shares of Quipt Home Medical Corp. for $3.10 per share in cash, representing a 120% premium over its recent closing price.
SCHEDULE 13D/A: Forager Fund Discloses 9.7% Stake in Quipt Home Medical, Enters Standstill Agreement
Forager Fund, L.P. and its affiliates have filed an amended Schedule 13D, disclosing a 9.7% beneficial ownership in Quipt Home Medical Corp. and the execution of a standstill agreement with the company.
SCHEDULE 13D/A: Quipt Home Medical Corp. and Kanen Group Forge Cooperation Agreement, Averting Proxy Contest
Quipt Home Medical Corp. and the Kanen Group have entered into a Cooperation Agreement, resolving a potential proxy contest and establishing terms for corporate governance and shareholder engagement.
SCHEDULE 13D/A: Activist Investor Group Led by Kanen Wealth Management Seeks Board Seats at Quipt Home Medical
Kanen Wealth Management and its affiliated funds have disclosed a 5.9% stake in Quipt Home Medical Corp. and announced their intention to nominate four directors to the company's board at the upcoming 2025 annual meeting.
SCHEDULE 13D: Kanen Wealth Management and Affiliates Disclose 5% Stake in Quipt Home Medical Corp., Citing Undervaluation
Kanen Wealth Management and its affiliated funds, Philotimo Fund, LP and Philotimo Focused Growth & Income Fund, have disclosed a collective 5.0% beneficial ownership stake in Quipt Home Medical Corp., stating their belief that the shares were undervalued.